Hypomethylation of CYP2E1 and DUSP22 Promoters Associated With Disease Activity and Erosive Disease Among Rheumatoid Arthritis Patients.
Amanda MokBrooke RheadCalliope HolingueXiaorong ShaoHong L QuachDiana QuachElizabeth SinclairJonathan GrafJohn ImbodenThomas LinkRuby HarrisonVladimir ChernitskiyLisa F BarcellosLindsey A CriswellPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2018)
Methylation signatures specific to RA clinical outcomes may have utility as biomarkers or predictors of exposure, disease progression, and disease severity.